Trends in Neuroendocrine Tumor in Friuli Venezia Giulia in the Last 20 Years Abstract #1044

Introduction: Epidemiological study conducted on patients (pts) with neuroendocrine tumors (NEN) at the regional referral center for Endocrinology and Metabolic Diseases of the Udine Hospital, Italy.
Aim(s): Data collected on 344 pts between 1990-2013 on residence, NEN type, age and metastases at diagnosis, survival, clinical course length, diagnostic tools, specialist visits, therapy. Survival and progression-free survival (PFS) analyzed by sex, NEN type, metastases at diagnosis.
Materials and methods: Mean age at diagnosis was 59.8 yrs (19-87 yrs), 50.3% males. Lungs and pancreas most affected; primarily non-functioning of the pancreas and typical carcinoid. Diagnoses of NEN/yr increased gradually to >30 cases/yr from 2009 on, greater in GEP-NEN. Between 2003-2013 there were 19.7 cases/100000 inhabitants; 20.8% had liver metastases at diagnosis. Survival was 1 mo - 23.7 yrs; 31.6% of pts died, 71.1% due to NEN.
Conference: 12th Annual ENETS Conference (2015)
Category: Epidemiology/Natural history/Prognosis - Descriptive epidemiology
Presenting Author: Prof Franco Grimaldi
Keywords: survival

To read results and conclusion, please login ...

Further abstracts you may be interested in

#793 Experience of a Single Italian Center with NET Patients
Introduction: The management of neuroendocrine tumors involves a multidisciplinary approach, so in 2004 the Endocrinology and Metabolic Unit developed a local/regional network to manage NET patients and to increase physician awareness of the disease.
Conference: 11th Annual ENETS Conference (2014)
Category: Epidemiology/Natural history/Prognosis - Prognosis
Presenting Author: Dr. Franco Grimaldi
#1325 Detection within a Neuroendocrine Tumor of High Levels of B-Lymphocyte Stimulator (BLyS) Correlates with a Greater Disease Severity
Introduction: .
Conference: 13th Annual ENETS conference (2016)
Category: Biomarkers
Presenting Author: Dr. Franco Grimaldi
Authors: Grimaldi F, Motta C, Cipri C, Tonelli V, ...
Keywords: Tumor marker
#1453 Clinicopathologic Features, Treatments and Survival of Patients with Ectopic Cushing’s Syndrome from Neuroendocrine Tumors: Data from an Italian Multicenter Study
Introduction: Literature on ectopic Cushing syndrome (ECS) and NET is scarce
Conference: 13th Annual ENETS conference (2016)
Category: Epidemiology/Natural history/Prognosis - Registries, nationwide and regional surveys
Presenting Author: Elisa Cosaro
Keywords: Ectopic ACTH
#36 A monocentric analysis of patients with pulmonary neuroendocrine tumors over 15 years: long term survival and life quality dependent from histological subtypes and surgical management
Introduction: Pulmonary neuroendocrine tumors substantially differ from epithelial tumors in terms of tumor biology and prognosis. In specialized interdisciplinary centers, a broad therapeutical armentarium can be used to achieve optimal treatment.
Conference: 7th Annual ENETS Conference (2010)
Category: Clinical
Presenting Author: Prof. Johannes N Hoffmann
Authors: Zahn S, Hornung H, Schick K S, Winter H, ...
#550 Predictors of Survival Following Y90 DOTATOC/DOTATATE Therapy
Introduction: Y90-DOTATATE and Y90-DOTATOC are established treatments for patients with advanced neuroendocrine tumours. Outcomes associated with improved survival following therapy are still unclear.
Conference: 9th Annual ENETS Conference (2012)
Category: Clinical
Presenting Author: Mr Timothy Gilbert
Authors: Gilbert T, Mckane G, Banks M, Poston G, ...